journal article·2013-12

Synthesis and bio-evaluation of novel hypocrellin derivatives: Potential photosensitizers for photodynamic therapy of age-related macular degeneration

Hong Deng, Tinghui Li, Jie Xie, Naiyan Huang, Ying Gu, Jingquan Zhao

Dyes and Pigments· Volume 99· Issue 3
Publisher page

Abstract

Abstract The phototherapeutic window from 600 to 900 nm is necessary for photodynamic therapy (PDT) of solid tumors, but may not suitable for PDT of some microvascular diseases, like age-related macular degeneration (AMD), because of its deep penetration. Moreover, absorption of some neighboring photoreceptors should be avoided for PDT of AMD. Considering these, yellow-orange light may be a proper phototherapeutic window of AMD. Herein, two novel amino-alkyl-sulfonic acid-substituted hypocrellin B derivatives, 3 and 4 were designed and synthesized. They exhibited the maximal absorption at yellow-orange light, and possessed higher PDT activity than 2 , proved by the in vitro or in vivo experiments. Besides, 4 showed much higher PDT activity than 3 , ascribed to its higher cellular uptake suggested by its optimized amphiphilicity and liposome–mimic results. And the vascular leakage of 4 was close to 2 . Consequently, 4 has great potential for PDT of AMD or other superficial diseases.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Photodynamic Therapy Research Studies · Nanoplatforms for cancer theranostics · Porphyrin and Phthalocyanine Chemistry

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (52)

Show source-provided references
1. Photodynamic therapy (PDT): a short review on cellular mechanisms and cancer research applications for PDT10.1016/j.jphotobiol.2009.04.001 ↗
2. Photodynamic therapy: a clinical reality in the treatment of cancer10.1016/S1470-2045(00)00166-2 ↗
3. Twenty years of clinical experience with a new modality of vascular-targeted photodynamic therapy for port wine stains10.1111/j.1524-4725.2011.02129.x ↗
4. Age-related macular degeneration10.1016/S0140-6736(08)61759-6 ↗
5. CCR3 is a target for age-related macular degeneration diagnosis and therapy10.1038/nature08151 ↗
6. Age-related macular degeneration: diagnosis and management10.1093/bmb/ldn012 ↗
7. Effects on choroidal neovascularization after anti-VEGF upload using intravitreal ranibizumab, as determined by spectral domain-optical coherence tomography10.1167/iovs.09-4496 ↗
8. Clinical determination of tissue optical properties in vivo by spatially resolved reflectance measurements10.1117/12.508664 ↗
9. Wavelength selection in macular photocoagulation – tissue optics, thermal effects, and laser systems10.1016/S0161-6420(86)33637-6 ↗
10. An update on retinal laser therapy10.1111/j.1444-0938.2010.00529.x ↗
11. Photophysical and photosensitizing properties of benzoporphyrin derivative monoacid ring-a (Bpd-Ma)10.1111/j.1751-1097.1994.tb05042.x ↗
12. Synthesis, and in vitro and in vivo evaluation of a diphenylchlorin sensitizer for photodynamic therapy10.1016/S1011-1344(03)00020-4 ↗
13. Observation and interpretation of annulated porphyrins: studies on the photophysical properties of meso-tetraphenylmetalloporphyrins10.1021/jp0354705 ↗
14. Zinc azaphthalocyanines with pyridin-3-yloxy peripheral substituents10.1016/j.poly.2009.05.060 ↗
15. Synthesis and characterization of solubility enhanced metal-free phthalocyanines for liquid crystal display black matrix of low dielectric constant10.1016/j.dyepig.2011.08.001 ↗
16. Antiviral activities of photoactive perylenequinones10.1111/j.1751-1097.1997.tb08570.x ↗
17. Efficacy of hypocrellin pharmacokinetics in phototherapy
18. Hypocrellin-based photodynamic sensitizers
19. Biophysical evaluation of two red-shifted hypocrellin B derivatives as novel PDT agents10.1016/j.jphotobiol.2008.09.007 ↗
20. A novel hypocrellin B derivative designed and synthesized by taking consideration to both drug delivery and biological photodynamic activity10.1016/j.jphotobiol.2008.11.008 ↗
21. Novel surfactant-like hypocrellin derivatives to achieve simultaneous drug delivery in blood plasma and cell uptake10.1111/j.1751-1097.2010.00711.x ↗
22. A new Co(III)-hypocrellin B complex with enhanced photonuclease activity10.1016/j.jinorgbio.2011.03.021 ↗
23. Oxovanadium(IV) based hypocrellin B complexes with enhanced photodynamic activity10.1039/C1DT11401H ↗
24. Hypocrellin-loaded gold nanocages with high two-photon efficiency for photothermal/photodynamic cancer therapy in vitro10.1021/nn302634m ↗
25. ESR studies of the photodynamic properties of a long-wavelength and water-soluble hypocrellin B derivative: photogeneration of semiquinone radical anion and activated oxygen10.1016/S1010-6030(99)00036-2 ↗
26. Photodynamic activity and potential usability of 14-carboxyl hypocrellin B10.1039/b211388k ↗
27. A tyrosine-modified hypocrellin B with affinity for and photodamaging ability towards calf thymus DNA10.1039/b309024h ↗
28. Preparation of a novel hypocrellin derivative and its photochemical, photophysical properties10.1016/j.dyepig.2004.02.010 ↗
29. Photodynamic properties of a bispyrrolecarboxamide-modified hypocrellin B: the role of affinity and ascorbic acid10.1021/jp7121467 ↗
30. Studies of the sulfonation of hypocrellin-A and the photodynamic actions of the product10.1016/1011-1344(93)80013-Y ↗
31. Synthesis of hydrophilic conjugated porphyrin dimers for one-photon and two-photon photodynamic therapy at NIR wavelengths10.1039/b814789b ↗
32. The presence of substituents on the aryl moiety of the aryl phosphoramidate derivative of d4T enhances anti-HIV efficacy in cell culture: a structure–activity relationship10.1021/jm9803931 ↗
33. Role of lipophilicity in determining cellular uptake and antitumour activity of gold phosphine complexes10.1007/s002800000166 ↗
34. Conversion of hypocrellin A in alkaline and neutral media
35. Quantitative and site-directed chemical modification of hypocrellins toward direct drug delivery and effective photodynamic activity10.1021/jm2017368 ↗
36. Photosensitization by anticancer agents. 12. Perylene quinonoid pigments, a novel type of singlet oxygen sensitizer10.1016/1010-6030(92)85002-C ↗
37. Comparative properties and methods of preparation of lipid vesicles (liposomes)10.1146/annurev.bb.09.060180.002343 ↗
38. {(1R,2R,4R)-4-methyl-1,2-cyclohexanediamine}oxalatoplatinum(II): a novel enantiomerically pure oxaliplatin derivative showing improved anticancer activity in vivo10.1021/jm100953c ↗
39. A new drug-screening procedure for photosensitizing agents used in photodynamic therapy for CNV
40. Electron-donor properties of hydroxyl ion
41. Studies on the sulfonation of hypocrellins at the 13-position and the reaction mechanism
42. Protective effect of taurine against free radicals damage in the rat myocardium10.1016/j.etp.2004.08.004 ↗
43. Taurine protects against methotrexate-induced toxicity and inhibits leukocyte death10.1016/j.taap.2005.03.009 ↗
44. The salt effect on riboflavin-photosensitized substitution of the sulfo group for bromine in 1-bromo-2-hydroxynaphthalene10.1134/S0018143909040079 ↗
45. First synthesis of methylated hypocrellin and its fluorescent excited state: a cautionary tale10.1021/jo026554x ↗
46. Photodynamic action of hypocrellin dyes: structure–activity relationships10.1016/S0143-7208(99)00074-1 ↗
47. Photodynamic therapy in the treatment of microbial infections: basic principles and perspective applications10.1002/lsm.20361 ↗
48. Preparation of poly(ethylene glycol)-attached dendrimers encapsulating photosensitizers for application to photodynamic therapy10.1021/bc060244u ↗
49. Recognition of various biomolecules by the environment-sensitive spectral responses of hypocrellin B10.1039/b618678e ↗
50. Lipophilic drug transfer between liposomal and biological membranes: what does it mean for parenteral and oral drug delivery?10.1080/08982100600848702 ↗
51. Encapsulation of porphyrins and chlorins in biodegradable nanoparticles: the effect of dye lipophilicity on the extravasation and the photothrombic activity. A comparative study10.1016/j.jphotobiol.2005.02.003 ↗
52. Intravital microscopic analysis of vascular perfusion and macromolecule extravasation after photodynamic vascular targeting therapy10.1007/s11095-008-9604-5 ↗